ReviewReview of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist
Key words
COVID-19 drug treatment
drug eruptions
drug-related side effects and adverse reactions
review
Abbreviations used
FDA
US Food and Drug Administration
IL
interleukin
MERS
Middle Eastern respiratory syndrome
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
SJS
Stevens-Johnson syndrome
Cited by (0)
Funding sources: None
Conflicts of interest: None disclosed.
IRB approval status: Not applicable.
Reprints not available from the authors.
© 2020 by the American Academy of Dermatology, Inc.